Professor of Pharmacy Practice Creighton University School of Pharmacy & Health Professions Omaha, Nebraska, United States
Emily Knezevich, PharmD, BCPS, CDCES, FCCP: abbott: Grant Recipient (Ongoing); Dexcom: Grant Recipient (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Last year Congress passed the Inflation Reduction Act (IRA), a new law that addresses prescription drug costs and drug prices in the Medicare program. The U.S. Department of Health & Human Services (HHS) is actively working on implementation of IRA provisions, and pharmacies should be paying close attention to how specific changes in the new law could affect their businesses. Attend this presentation for an overview of the IRA provisions that specifically impact pharmacies and how they will alter the Part D landscape.
This activity is sponsored by an independent educational grant from Abbott Diabetes Care.
Keeping up with all the new technology in diabetes can be daunting. This session will share the latest information on new products and features, highlighting improved outcomes, challenges in implementation or use, and approaches to overcome barriers.
Describe new technologies for people with diabetes, including continuous glucose monitoring, connected insulin pens, and corresponding mobile applications.
Discuss which patients are most appropriate for diverse types of diabetes technologies.
Identify best practices in billing for various diabetes technologies.
Recognize ways to overcome challenges and barriers to use of diabetes technologies.